Global genomic surveillance uncovers emergence and spatiotemporal patterns of World Health Organization priority antibiotic resistance in invasive Salmonella

Abstract Antimicrobial resistance (AMR) in invasive Salmonella infections remains a global public health concern, and enhanced high-quality genomic surveillance is essential to inform guidelines and policies. Here, we aimed to describe clinically key antibiotic resistance trends in invasive Salmonella infections using 7691 isolates derived from national surveillance and publicly available datasets between 1954 and 2024. 29 (37.7%) of 77 countries identified at least one isolate with resistance or decreased susceptibility to ciprofloxacin, 25 (32.5%) and 29 (37.7%) countries resistance or decreased susceptibility to ceftriaxone and cefixime, 8 (10.4%) countries resistance to azithromycin, 15 (19.5%) countries resistance to fosfomycin, 10 (13.0%) countries resistance to colistin. Overall, 7.39% of 7691 isolates were resistant or decreased susceptibility to ciprofloxacin, 7.91% reported resistance or decreased susceptibility to 3GCs, 4.23% reported resistance to fosfomycin, and 0.79% reported resistance to azithromycin. Globally, azithromycin resistance is increasing, as is resistance or decreased susceptibility to ciprofloxacin, 3GCs, and 4GCs. However, surveillance levels remain inadequate in African and South American regions. We generated a global map of clinically key antibiotic resistance genes in invasive Salmonella infections worldwide. This retrospective, global, longitudinal genomic epidemiology study on invasive Salmonella provides evidence-based data for clinical guidelines, genomic surveillance, AMR control, and public health policies.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-08-17
DOI
https://doi.org/10.1038/s41467-026-76354-1
Primary Topic
Salmonella and Campylobacter epidemiology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Global genomic surveillance uncovers emergence and spatiotemporal patterns of World Health Organization priority antibiotic resistance in invasive Salmonella

Mingliu Wang, George F. Gao, Jinhua Meng, Chunmei Jing et al.
Nature Communications
Salmonella and Campylobacter epidemiology
article

Global genomic surveillance uncovers emergence and spatiotemporal patterns of World Health Organization priority antibiotic resistance in invasive Salmonella

Mingliu Wang, George F. Gao, Jinhua Meng, Chunmei Jing, Mei Zeng, Xuebin Xu, Mengqi Qu, Yufeng Qiu, Yanan Wang, Jiale Chen, Sufang Ma, Xiaolu Pang, Hongxia Yang, Meilian Huang, Yuhang Pei, Na Lyu, Baoli Zhu, Jiangtao Wang, Yue Liu, Chaochao Zhao, Ziru Yang, Yibin Zhou, Wenqing Wang, Wufuer. Xiayidan
article en

Abstract

Abstract Antimicrobial resistance (AMR) in invasive Salmonella infections remains a global public health concern, and enhanced high-quality genomic surveillance is essential to inform guidelines and policies. Here, we aimed to describe clinically key antibiotic resistance trends in invasive Salmonella infections using 7691 isolates derived from national surveillance and publicly available datasets between 1954 and 2024. 29 (37.7%) of 77 countries identified at least one isolate with resistance or decreased susceptibility to ciprofloxacin, 25 (32.5%) and 29 (37.7%) countries resistance or decreased susceptibility to ceftriaxone and cefixime, 8 (10.4%) countries resistance to azithromycin, 15 (19.5%) countries resistance to fosfomycin, 10 (13.0%) countries resistance to colistin. Overall, 7.39% of 7691 isolates were resistant or decreased susceptibility to ciprofloxacin, 7.91% reported resistance or decreased susceptibility to 3GCs, 4.23% reported resistance to fosfomycin, and 0.79% reported resistance to azithromycin. Globally, azithromycin resistance is increasing, as is resistance or decreased susceptibility to ciprofloxacin, 3GCs, and 4GCs. However, surveillance levels remain inadequate in African and South American regions. We generated a global map of clinically key antibiotic resistance genes in invasive Salmonella infections worldwide. This retrospective, global, longitudinal genomic epidemiology study on invasive Salmonella provides evidence-based data for clinical guidelines, genomic surveillance, AMR control, and public health policies.

Nature Communications
Shanxi Medical University (CN), Chinese Center For Disease Control and Prevention (CN), Chinese Academy of Sciences (CN), The Fourth People's Hospital (CN), Xinjiang Uygur Autonomous Region Disease Prevention and Control Center (CN), Education Department of Fujian Province (CN), Shanghai Pudong Institute of Education Development (CN), Guangxi Center for Disease Prevention and Control (CN), Shanxi Provincial Children's Hospital (CN), Children's Hospital of Fudan University (CN), Children's Hospital of Chongqing Medical University (CN), Shanghai Municipal Center For Disease Control Prevention (CN), Children’s Hospital of Fudan University Xiamen Branch (CN), University of Chinese Academy of Sciences (CN), Henan Agricultural University (CN), Chongqing Medical University (CN)
Henan Agricultural University, National Key Research and Development Program of China
Openalex Percentile: Top 12%
Salmonella and Campylobacter epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.